Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Aldeyra The (ALDX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aldeyra The's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.930 -0.010    -0.25%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
4.100
+0.170
+4.326%
18:09:29 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 264,877
  • Bid/Ask: 3.840 / 4.100
  • Day's Range: 3.830 - 3.975
Aldeyra The 3.930 -0.010 -0.25%

Aldeyra The Company Profile

 
Get an in-depth profile of Aldeyra The, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

10

Equity Type

ORD

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Contact Information

Address 131 Hartwell Avenue Suite 320
Lexington, 02421
United States
Phone 781 761 4904
Fax 339 674 6495

Top Executives

Name Age Since Title
Ben R. Bronstein 71 2010 Independent Director
Martin J. Joyce 67 2013 Independent Director
Paul M. Karpecki 54 2020 Member of Anterior Segment Scientific Advisory Board
Gary M. Phillips 55 2009 Independent Director
Richard Huntington Douglas 68 2016 Independent Chair of the Board
Todd C. Brady 49 2005 CEO, President & Director
David Chu - - Member of Anterior Segment Scientific Advisory Board
Nancy Miller-Rich 62 2020 Independent Director
Neal S. Walker 51 2013 Independent Director
John J. Sheppard - - Member of Anterior Segment Scientific Advisory Board
Jay S. Duker 63 - Member of Retina Segment Scientific Advisory Board
Dean Eliott - - Member of Retina Segment Scientific Advisory Board
Jeffrey S. Heier 61 - Member of Retina Segment Scientific Advisory Board
Quan Dong Nguyen - - Member of Retina Segment Scientific Advisory Board
Carl D. Regillo - - Member of Retina Segment Scientific Advisory Board
Victor Perez - - Member of Anterior Segment Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALDX Comments

Write your thoughts about Aldeyra The
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeremy Glaser
Jeremy Glaser Dec 22, 2023 9:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
definitely see this to Rocket real soon
CEM BAŞBAY
CEM BAŞBAY Dec 19, 2023 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go up up up …
Jeremy Glaser
Jeremy Glaser Dec 19, 2023 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gonna go a lot higher
Robi Zambo
Robi Zambo Nov 25, 2023 5:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Upcoming BPIQ Movers: $ALDX PDUFA 23/11
Alex B
Alex B Jan 20, 2023 4:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
6.00 bucks is a very good for a fresh entry or add to exciting position imo , long here
Vj Goswami
Vj Goswami Oct 06, 2022 9:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can we buy it today?
Mark McMillan
Mark McMillan Dec 21, 2021 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so they didn't get all the results they were looking for. This is way over reacting. to drop 50% on this is a definite buy for me!!
lorenzo bertello
lorenzo bertello Nov 29, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bottomless pit
Marco Singarella
Marco Singarella Oct 13, 2021 5:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is there still potential to go up for this stock?
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Apr 27, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ocugen
Ely Cassirer
Ely Cassirer Feb 11, 2021 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To the MOON
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email